BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38135007)

  • 1. FXR controls insulin content by regulating Foxa2-mediated insulin transcription.
    Yan D; Lv M; Kong X; Feng L; Ying Y; Liu W; Wang X; Ma X
    Biochim Biophys Acta Mol Cell Res; 2024 Feb; 1871(2):119655. PubMed ID: 38135007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression.
    Kong X; Tu Y; Li B; Zhang L; Feng L; Wang L; Zhang L; Zhou H; Hua X; Ma X
    Mol Metab; 2019 Nov; 29():1-11. PubMed ID: 31668381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Farnesoid X receptor contributes to body weight-independent improvements in glycemic control after Roux-en-Y gastric bypass surgery in diet-induced obese mice.
    Li K; Zou J; Li S; Guo J; Shi W; Wang B; Han X; Zhang H; Zhang P; Miao Z; Li Y
    Mol Metab; 2020 Jul; 37():100980. PubMed ID: 32305491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FXR/Menin-mediated epigenetic regulation of E2F3 expression controls β-cell proliferation and is increased in islets from diabetic GK rats after RYGB.
    Kong X; Yang C; Li B; Yan D; Yang Y; Cao C; Xing B; Ma X
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167136. PubMed ID: 38531483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioneer factor Foxa2 enables ligand-dependent activation of type II nuclear receptors FXR and LXRα.
    Kain J; Wei X; Reddy NA; Price AJ; Woods C; Bochkis IM
    Mol Metab; 2021 Nov; 53():101291. PubMed ID: 34246806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FXR Mediates Adenylyl Cyclase 8 Expression in Pancreatic
    Kong X; Li B; Deng Y; Ma X
    J Diabetes Res; 2019; 2019():8915818. PubMed ID: 31485455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioneer Factor Foxa2 Mediates Chromatin Conformation Changes for Activation of Bile Acid Targets of FXR.
    Hao Y; Han L; Wu A; Bochkis IM
    Cell Mol Gastroenterol Hepatol; 2024; 17(2):237-249. PubMed ID: 37879405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis.
    Ploton M; Mazuy C; Gheeraert C; Dubois V; Berthier A; Dubois-Chevalier J; Maréchal X; Bantubungi K; Diemer H; Cianférani S; Strub JM; Helleboid-Chapman A; Eeckhoute J; Staels B; Lefebvre P
    J Hepatol; 2018 Nov; 69(5):1099-1109. PubMed ID: 29981427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 signaling-regulated SNAP25 is involved in improved insulin secretion in diabetic GK rats after Roux-en-Y gastric bypass surgery.
    Kong X; Lin C; Yang C; Wang X; Li B; Yan D; Yang Y; Hu A; Chen Y; Xu X; Ma X
    Mol Biol Rep; 2024 Jan; 51(1):123. PubMed ID: 38227062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional co-activator peroxisome proliferator-activated receptor (PPAR)gamma co-activator-1beta is involved in the regulation of glucose-stimulated insulin secretion in INS-1E cells.
    Oberkofler H; Hafner M; Felder T; Krempler F; Patsch W
    J Mol Med (Berl); 2009 Mar; 87(3):299-306. PubMed ID: 19082571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression.
    Wang S; Feng R; Wang SS; Liu H; Shao C; Li Y; Link F; Munker S; Liebe R; Meyer C; Burgermeister E; Ebert M; Dooley S; Ding H; Weng H
    Gut; 2023 Mar; 72(3):549-559. PubMed ID: 35444014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foxa2 (HNF3beta ) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release.
    Wang H; Gauthier BR; Hagenfeldt-Johansson KA; Iezzi M; Wollheim CB
    J Biol Chem; 2002 May; 277(20):17564-70. PubMed ID: 11875061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
    Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
    Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte nuclear factors 1α/4α and forkhead box A2 regulate the solute carrier 2A2 (Slc2a2) gene expression in the liver and kidney of diabetic rats.
    David-Silva A; Freitas HS; Okamoto MM; Sabino-Silva R; Schaan BD; Machado UF
    Life Sci; 2013 Nov; 93(22):805-13. PubMed ID: 24157454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of IRS-1 expression in Goto-Kakizaki rats following Roux-en-Y gastric bypass surgery: resolution of type 2 diabetes?
    Li SQ; Zhou Y; Wang Y; Liu Y; Geng DH; Liu JG
    Tohoku J Exp Med; 2011 Nov; 225(3):179-86. PubMed ID: 22001674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxa2 regulates multiple pathways of insulin secretion.
    Lantz KA; Vatamaniuk MZ; Brestelli JE; Friedman JR; Matschinsky FM; Kaestner KH
    J Clin Invest; 2004 Aug; 114(4):512-20. PubMed ID: 15314688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic regulation of PDX-1 and FoxO1 expression by FoxA2 in dexamethasone-induced pancreatic β-cells dysfunction.
    Chen F; Zhu Y; Tang X; Sun Y; Jia W; Sun Y; Han X
    Endocrinology; 2011 May; 152(5):1779-88. PubMed ID: 21385937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes mitigation in the diabetic Goto-Kakizaki rat by elevated bile acids following a common-bile-duct surgery.
    Gao F; Zhang X; Zhou L; Zhou S; Zheng Y; Yu J; Fan W; Zhu Y; Han X
    Metabolism; 2016 Feb; 65(2):78-88. PubMed ID: 26773931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between Atorvastatin and the Farnesoid X Receptor Impair Insulinotropic Effects of Bile Acids and Modulate Diabetogenic Risk.
    Hoffmeister T; Kaiser J; Lüdtke S; Drews G; Düfer M
    Mol Pharmacol; 2020 Mar; 97(3):202-211. PubMed ID: 31911428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.